|
시장보고서
상품코드
1907941
피임약 시장 : 정제 카테고리별, 호르몬 조성별, 유효성분 함유량별, 프로게스틴 세대별, 유저 연령층별, 처방 상황별, 브랜드유형별, 적용 요구별, 포장 형태별, 유통 채널별, 지역별Contraceptive Pills Market, By Pill Category, By Hormonal Composition,By Dosage Strength, By Progestin Generation, By User Age Group, By Prescription Status, By Brand Type,By Application Need,By Packaging Format, By Distribution Channel, By Geography |
||||||
피임약 시장은 2025년에 81억 2,000만 달러로 추정되고, 2032년까지 131억 2,000만 달러에 이를 것으로 예측됩니다. 2025년부터 2032년까지 연평균 복합 성장률(CAGR) 7.1%로 성장할 것으로 전망되고 있습니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준 연도 | 2024년 | 시장 규모(2025년) | 81억 2,000만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2025-2032년 |
| 예측기간 CAGR(2025-2032년) | 7.10% | 예측 금액(2032년) | 131억 2,000만 달러 |
세계의 피임약 시장은 생식 의료 산업의 중요한 부분이며 호르몬 조절 메커니즘을 통해 원치 않는 임신을 예방하기위한 경구 피임약을 포함합니다. 이 의약품은 주로 합성 에스트로겐과 프로게스틴 호르몬을 포함하며 배란 억제, 자궁 경관 점액의 점성 변화, 자궁 내막의 변화를 통해 임신에 대한 여러 장벽을 형성합니다.
1960년대에 최초의 경구 피임약이 도입된 이래, 시장은 크게 진화하고 기본적인 호르몬 제형에서 효과를 유지하면서 부작용을 최소화하는 정교한 저용량 배합제로 변용해 왔습니다. 현대의 피임약은 에스트로겐과 프로게스틴을 모두 포함하는 복합제와 프로게스틴만을 포함하는 단독제로 분류되며, 각각 다른 환자층에 고유한 이점을 제공합니다.
업계에서는 단상, 이상, 삼상, 연장주기제품, 사후 피임약 등 다양한 제제를 통해 다양한 소비자 요구에 대응하고 있습니다. 이 시장은 제약 제조업체, 의료 제공업체, 규제 기관 및 최종 사용자가 참여하는 복잡한 생태계에서 운영되며, 유통 경로는 병원, 클리닉, 약국 및 점점 더 확대되는 온라인 플랫폼으로 확산되고 있습니다. 피임약 시장은 편의성 향상, 부작용 경감, 피임 이외의 치료 효과 강화 등 변화하는 소비자의 요구에 부응하면서 의료 분야에서의 혁신을 계속 견인하고 있습니다.
시장 역학
세계의 피임약 시장은 여러 상호 관련 요소에 의해 견인되어 견고한 성장을 이루고 있습니다. 특히 개발도상지역에서는 정부주도의 피임수단에 대한 접근촉진책과 피임방법에 대한 이해를 깊게 하는 교육프로그램이 실시되고 있으며, 가족계획과 생식건강에 대한 의식의 고조가 시장 확대의 주요한 추진력이 되고 있습니다.
세계 여성의 노동력 참여율 상승은 경력 목표에 따른 임신 계획을 가능하게 하는 신뢰할 수 있는 피임법에 대한 수요를 창출하고 있습니다. 동시에 여성의 임파워먼트와 생식에 대한 권리에 대한 중시가 높아짐에 따라 피임법의 보급률은 더욱 가속화되고 있습니다. 많은 국가의 의료 인프라 개선 및 피임약 보험 적용 범위의 확대는 시장 침투를 촉진하고 있습니다. 이에 더해, 저용량 호르몬이나 새로운 투여 방법에 의한 부작용 경감과 유저 체험의 향상을 실현하는 지속적인 제품 혁신이 시장을 지지하고 있습니다.
그러나 보수적 사회에서 피임 사용에 대한 문화적 종교적 반대 등 시장에는 중대한 억제요인이 존재합니다. 이로 인해 특정 지역에서는 시장 침투가 제한되는 반면, 혈전증 위험 증가, 심혈관 합병증, 기분 장애와 같은 장기적인 호르몬 피임약 사용에 대한 안전 우려가 잠재적인 사용자와 의료 제공업체들 사이에서 망설임을 낳습니다.
피임약 승인 과정에 대한 엄격한 규제 요건은 개발 비용과 시장 출시까지의 시간을 증가시킵니다. 한편, 자궁내 피임기구, 임플란트, 장벽법 등의 대체 피임법의 존재는 경쟁압력을 강화하고 있습니다. 큰 기회는 젊은 인구가 늘어나는 서비스가 없는 신흥 시장, 신기술에 의해 가능해진 개별화된 호르몬 솔루션, 그리고 여드름, 자궁내막증, 다낭성 난소 증후군(PCOS) 등에 대한 피임약의 광범위한 치료 용도에 있습니다. 이들은 잠재적인 시장 규모를 확대하고 새로운 수익원을 개척합니다.
이 보고서의 주요 특징
- 본 보고서는 세계의 피임약 시장을 상세하게 분석하여 2024년을 기준 연도로 한 예측기간(2025-2032년) 시장 규모 및 CAGR을 제공합니다.
- 또한 각 부문의 잠재적인 수익 기회를 밝히고 이 시장의 매력적인 투자 제안 행렬을 설명합니다.
- 또한 시장 성장 촉진요인 및 억제요인과 기회, 신제품의 상시와 승인, 시장 동향, 지역별 전망, 주요기업이 채택하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
- 세계 피임약 시장의 주요 기업 프로파일은 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등 다음 매개 변수를 기반으로 게시됩니다.
- 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형 업데이트, 시장 확대, 마케팅 전술에 대한 충분한 정보를 바탕으로 의사 결정을 내릴 수 있습니다.
- '세계 피임약 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자를 지원합니다.
- 이해관계자는 세계 피임약 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사 결정을 용이하게 할 수 있습니다.
목차
제1장 분석 목적과 전제조건
- 분석 목적
- 전제조건
- 약어
제2장 시장 전망
- 보고서 설명
- 시장 정의와 범위
- 주요 요약
제3장 시장 역학, 규제 및 동향 분석
- 시장 역학
- 성장 촉진요인
- 억제요인
- 기회
- 영향 분석
- 주요 발전
- 규제 시나리오
- 제품 출시/승인
- PEST 분석
- Porter's Five Forces 분석
- 기업 합병 및 인수(M&A) 시나리오
- 업계 동향
제4장 세계의 피임약 시장 : 정제 카테고리별(2020-2032년)
- 복합경구피임약(COC)
- 프로게스틴 단독 피임약(POP/미니피임약)
- 사후피임약(ECP)
제5장 세계의 피임약 시장 : 호르몬 조성별(2020-2032년)
- 단상 피임약
- 이상 피임약
- 삼상 피임약
제6장 세계의 피임약 시장 : 유효 성분 함유량별(2020-2032년)
- 저용량 피임약
- 표준용량 피임약
- 고용량 피임약
제7장 세계의 피임약 시장 : 프로게스틴 세대별(2020-2032년)
- 제1세대 프로게스틴 정제
- 제2세대 프로게스틴 정제
- 제3세대 프로게스틴 정제
- 제4세대 프로게스틴 정제
제8장 세계 피임약 시장 : 유저 연령층별(2020-2032년)
- 15-19세
- 20-29세
- 30-39세
- 40세 이상
제9장 세계 피임약 시장 : 처방 상황별(2020-2032년)
- 처방전 기반
- 일반의약품
제10장 세계의 피임약 시장 : 브랜드유형별(2020-2032년)
- 제네릭
- 브랜드 의약품
제11장 세계의 피임약 시장 : 적용 요구별(2020-2032년)
- 피임
- 호르몬 조절
- 여드름 치료
- 월경주기 관리
제12장 세계의 피임약 시장 : 포장 형태별(2020-2032년)
- 21일 팩
- 24일 팩
- 28일 팩
- 91일 팩
제13장 세계 피임약 시장 : 유통 채널별(2020-2032년)
- 병원 약국
- 소매 약국
- 온라인 약국
제14장 세계의 피임약 시장 : 지역별(2020-2032년)
- 북미
- 미국
- 캐나다
- 라틴아메리카
- 브라질
- 아르헨티나
- 멕시코
- 기타 라틴아메리카
- 유럽
- 독일
- 영국
- 스페인
- 프랑스
- 이탈리아
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 중동
- GCC 국가
- 이스라엘
- 기타 중동
- 아프리카
- 남아프리카
- 북아프리카
- 중앙 아프리카
제15장 경쟁 구도
- Pfizer Inc
- Bayer AG
- Organon &Co
- Teva Pharmaceutical Industries Ltd
- Mylan NV(Viatris Inc)
- Johnson &Johnson
- Gedeon Richter Plc
- Lupin Limited
- Cipla Limited
- HLL Lifecare Limited
- Piramal Enterprises Limited
- Sun Pharmaceutical Industries Ltd
- Allergan plc(AbbVie Inc)
- Cadila Healthcare Ltd(Zydus Lifesciences)
- Torrent Pharmaceuticals Ltd
제16장 애널리스트의 제안
- 기회
- 애널리스트의 견해
- Coherent Opportunity Map(COM)
제17장 참고문헌과 분석 방법
- 참고문헌
- 분석 방법
- Coherent Market Insights에 대해
Contraceptive Pills Market is estimated to be valued at USD 8.12 Bn in 2025 and is expected to reach USD 13.12 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.1% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 8.12 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 7.10% | 2032 Value Projection: | USD 13.12 Bn |
The global contraceptive pills market represents a critical segment of the reproductive health industry, encompassing oral contraceptive medications designed to prevent unwanted pregnancies through hormonal regulation mechanisms. These pharmaceutical products, primarily containing synthetic versions of estrogen and progestin hormones, work by suppressing ovulation, altering cervical mucus consistency, and modifying the uterine lining to create multiple barriers against conception.
The market has evolved significantly since the introduction of the first oral contraceptive in the 1960s, transforming from basic hormonal formulations to sophisticated, low-dose combinations that minimize side effects while maintaining efficacy. Modern contraceptive pills are categorized into combination pills containing both estrogen and progestin, and progestin-only pills, each offering distinct advantages for different patient demographics.
The industry serves diverse consumer needs through various formulations including monophasic, biphasic, and triphasic pills, extended-cycle options, and emergency contraceptives. This market operates within a complex ecosystem involving pharmaceutical manufacturers, healthcare providers, regulatory bodies, and end-users, with distribution channels spanning hospitals, clinics, pharmacies, and increasingly, online platforms. The contraceptive pills market continues to drive innovation in reproductive healthcare, addressing evolving consumer preferences for convenience, reduced side effects, and enhanced therapeutic benefits beyond contraception.
Market Dynamics
The global contraceptive pills market experiences robust growth driven by multiple interconnected factors, with increasing awareness about family planning and reproductive health serving as the primary catalyst for market expansion, particularly in developing regions where government initiatives promote contraceptive accessibility and education programs enhance understanding of birth control options.
Rising female workforce participation globally creates demand for reliable contraceptive methods that enable women to plan pregnancies according to career goals, while growing emphasis on women's empowerment and reproductive rights further accelerates adoption rates. Healthcare infrastructure improvements and expanding insurance coverage for contraceptives in many countries facilitate market penetration, supported by continuous product innovations that reduce side effects and improve user experience through lower hormone doses and novel delivery mechanisms.
However, the market faces significant restraints including cultural and religious opposition to contraceptive use in conservative societies, which limits market penetration in certain geographic regions, while safety concerns regarding long-term hormonal contraceptive use, including increased risks of blood clots, cardiovascular complications, and mood disorders, create hesitancy among potential users and healthcare providers.
Stringent regulatory requirements for contraceptive approval processes increase development costs and time-to-market, while the availability of alternative contraceptive methods such as intrauterine devices, implants, and barrier methods intensifies competitive pressure. Significant opportunities lie in underserved emerging markets with rising youth populations, personalized hormone solutions enabled by new technologies, and broader therapeutic uses of contraceptive pills for acne, endometriosis, and PCOS, which expand the total addressable market and unlock new revenue streams.
Key Features of the Study
- This report provides in-depth analysis of the global contraceptive pills market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global contraceptive pills market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Pfizer Inc, Bayer AG, Organon & Co, Teva Pharmaceutical Industries Ltd, Mylan NV (Viatris Inc), Johnson & Johnson, Gedeon Richter Plc, Lupin Limited, Cipla Limited, HLL Lifecare Limited, Piramal Enterprises Limited, Sun Pharmaceutical Industries Ltd, Allergan plc (AbbVie Inc), Cadila Healthcare Ltd (Zydus Lifesciences), and Torrent Pharmaceuticals Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global contraceptive pills market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global contraceptive pills market
Market Segmentation
- Pill Category Insights (Revenue, USD Bn, 2020 - 2032)
- Combined oral contraceptive pills (COCs)
- Progestin-only pills (POPs/mini-pills)
- Emergency contraceptive pills (ECPs)
- Hormonal Composition Insights (Revenue, USD Bn, 2020 - 2032)
- Monophasic Pills
- Biphasic Pills
- Triphasic Pills
- Dosage Strength Insights (Revenue, USD Bn, 2020 - 2032)
- Low-Dose Pills
- Standard-Dose Pills
- High-Dose Pills
- Progestin Generation Insights (Revenue, USD Bn, 2020 - 2032)
- First-Generation Progestin Pills
- Second-Generation Progestin Pills
- Third-Generation Progestin Pills
- Fourth-Generation Progestin Pills
- User Age Group Insights (Revenue, USD Bn, 2020 - 2032)
- 15-19 years
- 20-29 years
- 30-39 years
- 40+ years
- Prescription Status Insights (Revenue, USD Bn, 2020 - 2032)
- Prescription-Based Pills
- Over-the-Counter Pills
- Brand Type Insights (Revenue, USD Bn, 2020 - 2032)
- Generic
- Branded
- Application Need Insights (Revenue, USD Bn, 2020 - 2032)
- Birth Control
- Hormonal Regulation
- Acne Management
- Menstrual Cycle Management
- Packaging Format Insights (Revenue, USD Bn, 2020 - 2032)
- 21-Day Pack
- 24-Day Pack
- 28-Day Pack
- 91-Day Pack
- Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Pfizer Inc
- Bayer AG
- Organon & Co
- Teva Pharmaceutical Industries Ltd
- Mylan NV (Viatris Inc)
- Johnson & Johnson
- Gedeon Richter Plc
- Lupin Limited
- Cipla Limited
- HLL Lifecare Limited
- Piramal Enterprises Limited
- Sun Pharmaceutical Industries Ltd
- Allergan plc (AbbVie Inc)
- Cadila Healthcare Ltd (Zydus Lifesciences)
- Torrent Pharmaceuticals Ltd
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Contraceptive Pills Market, By Pill Category
- Global Contraceptive Pills Market, By Hormonal Composition
- Global Contraceptive Pills Market, By Dosage Strength
- Global Contraceptive Pills Market, By Progestin Generation
- Global Contraceptive Pills Market, By User Age Group
- Global Contraceptive Pills Market, By Prescription Status
- Global Contraceptive Pills Market, By Brand Type
- Global Contraceptive Pills Market, By Application Need
- Global Contraceptive Pills Market, By Packaging Format
- Global Contraceptive Pills Market, By Distribution Channel
- Global Contraceptive Pills Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Contraceptive Pills Market, By Pill Category, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Combined oral contraceptive pills (COCs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Progestin-only pills (POPs/mini-pills)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Emergency contraceptive pills (ECPs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Contraceptive Pills Market, By Hormonal Composition, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Monophasic Pills
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Biphasic Pills
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Triphasic Pills
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Contraceptive Pills Market, By Dosage Strength, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Low-Dose Pills
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Standard-Dose Pills
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- High-Dose Pills
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Contraceptive Pills Market, By Progestin Generation, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- First-Generation Progestin Pills
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Second-Generation Progestin Pills
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Third-Generation Progestin Pills
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Fourth-Generation Progestin Pills
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Contraceptive Pills Market, By User Age Group, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- 15-19 years
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- 20-29 years
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- 30-39 years
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- 40+ years
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Contraceptive Pills Market, By Prescription Status, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Prescription-Based Pills
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Over-the-Counter Pills
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
10. Global Contraceptive Pills Market, By Brand Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Generic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Branded
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
11. Global Contraceptive Pills Market, By Application Need, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Birth Control
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Hormonal Regulation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Acne Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Menstrual Cycle Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
12. Global Contraceptive Pills Market, By Packaging Format, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- 21-Day Pack
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- 24-Day Pack
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- 28-Day Pack
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- 91-Day Pack
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
13. Global Contraceptive Pills Market, By Distribution Channel, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
14. Global Contraceptive Pills Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Pill Category, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Hormonal Composition, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Progestin Generation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By User Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Prescription Status, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Brand Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application Need, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Packaging Format, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Pill Category, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Hormonal Composition, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Progestin Generation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By User Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Prescription Status, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Brand Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application Need, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Packaging Format, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Pill Category, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Hormonal Composition, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Progestin Generation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By User Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Prescription Status, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Brand Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application Need, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Packaging Format, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Pill Category, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Hormonal Composition, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Progestin Generation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By User Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Prescription Status, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Brand Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application Need, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Packaging Format, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Pill Category, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Hormonal Composition, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Progestin Generation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By User Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Prescription Status, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Brand Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application Need, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Packaging Format, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Pill Category, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Hormonal Composition, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Strength, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Progestin Generation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By User Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Prescription Status, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Brand Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application Need, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Packaging Format, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
15. Competitive Landscape
- Pfizer Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bayer AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Organon & Co
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mylan NV (Viatris Inc)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Gedeon Richter Plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lupin Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cipla Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- HLL Lifecare Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Piramal Enterprises Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sun Pharmaceutical Industries Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Allergan plc (AbbVie Inc)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cadila Healthcare Ltd (Zydus Lifesciences)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Torrent Pharmaceuticals Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
16. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
17. References and Research Methodology
- References
- Research Methodology
- About us
